Halberd Corp (HALB)

[Wilde Oscar]

They say the greatest artists know when their work is finished. You can ruin a great piece with “one more” adjustment. Watching Hartman turn down deals seems, to me, to have this same effect. I’m not sure to what point he’s trying to develop some of these technologies? If he doesn’t have the money to go all the way through the clinical trials he needs to understand when it’s time to put down his chisel, grab his pen and sign on the dotted line. Licensing deals, JV’s, this needs momentum from outside the Hartman PR machine.